drugset / Trial / NCT05350020

The Effects of Two Brands of Hydrocortisone Injected Intramuscularly Into Deltoid and Thigh Muscles

NCT05350020

Phase 4 Unknown 8 enrolled The London Clinic
Non-randomizedCrossoverOpen-labelOther

Summary

The study will be looking at the cortisol profiles of hypocortisolaemic patients following 100mg injections of two hydrocortisone preparations (Solu-Cortef® \& Hydrocortisone 100mg/ml). The investigators plan to use two methods of intramuscular injection to administer the preparations, one using a 1inch orange needle into the deltoid muscle and the other using a 1.25inch blue needle into the thigh muscle.

Timeline

Start
2022-03-14
Primary completion
2023-03
Completion
2023-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocortisone Other / unclassified 100 mg Intramuscular